Heart Failure 2019

aprile 25,2019


Prevention and treatment of heart failure 2019. conferenza medica internazionale

Date: aprile 25-26, 2019


Argomenti principali:

Acute Heart Failure
Advanced Heart Failure ManagementVAD and transplant
Basic ScienceTranslational
Current evidence-based management
Linee guida & Education
Etiology Phenotypes and Co-morbidities
Heart Failure with Preserved Ejection Fraction
Imaging and Biomarkers
Interventions Devices and Telemonitoring
Local session

Call for abstracts

Deadline for submission: 02/02/2018

The late abstract should contain newly achieved scientific work and results. The abstract has to be one full page (size A4, 210 X 297 mm) plus 1 per 3 explanatory pages with more detailed information about the work.
The abstract written in English and single spaced should include:

  • Applicable topic
  • Full title
  • Full name, affiliation, address, phone/fax/e-mail of one author for all correspondence
  • For all other co-authors, full name, affiliation and e-mail
  • Short introductive summary (ca.. 1,000 characters) for publication in the Programme Planner
  • Purpose of the work
  • Approach
  • Scientific innovation and relevance
  • Results and Conclusions


For questions concerning abstracts, please contact:

Ms. Kristina Zadorinae-mail uk@nbscience.com

The attendees of this event will get a chance to take part in:

  • master class on modern instrumental methods of diagnostics of rheumatic diseases- ultrasounds, MRI, osseo densitometry.
  • master class on increasing effective drug treatment of patients with rheumatic diseases.

Condizioni di partecipazione per i partecipanti:

Pacchetto di registrazione include certificato di partecipazione (lingua inglese) ,partecipazione alla sessione scientificaS, materiali della conferenza, visita alla mostra e 10-30% sconto per alloggio in hotel.




Online registration is required.No admission without registration confirmation.


(deadline – February 02, 2018)



Contatta NBScience

Dipartimento di educazione / conferenza:









terapia con cellule staminali